Omnicell Investor Presentation Deck
© 2023 Omnicell, Inc.
Reconciliation of GAAP revenues to non-GAAP revenues:
GAAP revenues
Omnicell, Inc.
Reconciliation of GAAP to Non-GAAP
(Unaudited, in thousands, except per share data and percentage)
Acquisition accounting impact related to deferred revenues
Non-GAAP revenues
Reconciliation of GAAP gross profit to non-GAAP gross profit:
GAAP gross profit
GAAP gross margin
Share-based compensation expense
Amortization of acquired intangibles
Acquisition accounting impact related to deferred revenues
Severance-related expenses
Non-GAAP gross profit
Non-GAAP gross margin
Reconciliation of GAAP operating expenses to non-GAAP operating expenses:
GAAP operating expenses
GAAP operating expenses % to total revenues
Share-based compensation expense
Amortization of acquired intangibles
Acquisition-related expenses
Impairment and abandonment of operating lease right-of-use and other assets related to facilities
Severance-related expenses
Non-GAAP operating expenses
Non-GAAP operating expenses as a % of total non-GAAP revenues
(a)
$
$
S
$
$
$
Three Months Ended March 31,
2023
2022
290,629
290,629
125,029
43.0%
144
130,206
44.8%
2,008
3,025
147,992
50.9%
(12,034)
(5,217)
(246)
(8,420)
(5,170)
116,905
40.2%
(a) For the three months ended March 31, 2023, impairment charges of other assets were approximately $0.6 million related to property and equipment in
connection with restructuring activities for optimization of certain leased facilities.
$
$
$
$
$
$
318,828
378
319,206
150,047
47.1%
2,244
3,314
378
156
156,139
48.9%
144,963
45.5%
(13,964)
(5,739)
(1,395)
(1,753)
(3,371)
118,741
37.2%
22View entire presentation